|
5-ETHYL-2'-DEOXYURIDINE
| S83524-100mg | 100mg | MedMol |
|
(5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸
| S20942-250mg | 250mg | MedMol |
|
(5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸
| S20942-1g | 1g | MedMol |
|
(5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-4-甲基-1-氧代戊基]-2,2,5-三甲基-4-恶唑烷羧酸
| S20942-5g | 5g | MedMol |
|
5-(Tert-Butyldimethylsilyloxy)-1-Pentanol
| S20869-250mg | 250mg | MedMol |
|
5-(Tert-Butyldimethylsilyloxy)-1-Pentanol
| S20869-1g | 1g | MedMol |
|
5-(Tert-Butyldimethylsilyloxy)-1-Pentanol
| S20869-5g | 5g | MedMol |
|
(5S,8S,14S,17S,20S,23S)-23-((2S,3R)-2-((S)-6-氨基-2-((S)-2-氨基-3-(1H-咪唑-4-基)丙胺基)己胺基)-3-羟基丁胺基)-17-苄基-5-氨基甲酰基-20-(羟甲基)-8-异丁基-14-异丙基-7
| S20781-25mg | 25mg | MedMol |
|
5H-Pyrazolo[3,4-b]quinolin-5-one, 1,4,6,7,8,9-hexahydro-3,7,7-trimethyl-4-(3-pyridinyl)-
| S89759-5mg | 5mg | MedMol |
|
5H-Pyrazolo[3,4-b]quinolin-5-one, 1,4,6,7,8,9-hexahydro-3,7,7-trimethyl-4-(3-pyridinyl)-
| S89759-10mg | 10mg | MedMol |
|
5H-Pyrazolo[3,4-b]quinolin-5-one, 1,4,6,7,8,9-hexahydro-3,7,7-trimethyl-4-(3-pyridinyl)-
| S89759-25mg | 25mg | MedMol |
|
5H-Pyrazolo[3,4-b]quinolin-5-one, 1,4,6,7,8,9-hexahydro-3,7,7-trimethyl-4-(3-pyridinyl)-
| S89759-100mg | 100mg | MedMol |
|
5-bromo-1H-Imidazole-4-carboxylic acid
| S88680-1g | 1g | MedMol |
|
5-HT2B antagonist-1
| S23438-25mg | 25mg | MedMol |
|
5-HT2B antagonist-1
| S23438-50mg | 50mg | MedMol |
|
5-chloro-N-(furan-2-ylmethyl)thiophene-2-sulfonamide
| S33341-10mg | 10mg | MedMol |
|
5-chloro-N-(furan-2-ylmethyl)thiophene-2-sulfonamide
| S33341-5mg | 5mg | MedMol |
|
5-(4-氟苯甲酰胺)-4H-1,2,4-三唑-3-羧酸甲酯
| S23419-10mg | 10mg | MedMol |
|
5-(4-氟苯甲酰胺)-4H-1,2,4-三唑-3-羧酸甲酯
| S23419-1mg | 1mg | MedMol |
|
5-HT2B antagonist-1
| S23438-5mg | 5mg | MedMol |
|
5-(4-氟苯甲酰胺)-4H-1,2,4-三唑-3-羧酸甲酯
| S23419-5mg | 5mg | MedMol |
|
5-(4-氟苯甲酰胺)-4H-1,2,4-三唑-3-羧酸甲酯
| S23419-25mg | 25mg | MedMol |
|
5-HT2B antagonist-1
| S23438-10mg | 10mg | MedMol |
|
5-chloro-N-(furan-2-ylmethyl)thiophene-2-sulfonamide
| S33341-100mg | 100mg | MedMol |
|
5-chloro-N-(furan-2-ylmethyl)thiophene-2-sulfonamide
| S33341-25mg | 25mg | MedMol |
|
(5-FLUORO-1H-INDAZOL-3-YL)-ACETIC ACID
| S88210-1g | 1g | MedMol |
|
(5-FLUORO-1H-INDAZOL-3-YL)-ACETIC ACID
| S88210-250mg | 250mg | MedMol |
|
(5-FLUORO-1H-INDAZOL-3-YL)-ACETIC ACID
| S88210-100mg | 100mg | MedMol |
|
5-HT3 antagonist-4i
| S89670-5mg | 5mg | MedMol |
|
5-HT3 antagonist-4i
| S89670-10mg | 10mg | MedMol |
|
5-HT3 antagonist-4i
| S89670-25mg | 25mg | MedMol |
|
5-HT3 antagonist-4i
| S89670-100mg | 100mg | MedMol |
|
5-HT3 antagonist 5
| S89618-5mg | 5mg | MedMol |
|
5-HT3 antagonist 5
| S89618-10mg | 10mg | MedMol |
|
5-HT3 antagonist 5
| S89618-25mg | 25mg | MedMol |
|
5-HT3 antagonist 5
| S89618-100mg | 100mg | MedMol |
|
5-Bromo-4-nitrothiophene-2-carboxylic acid methyl ester
| S85202-5g | 5g | MedMol |
|
5-Ph-IAA
| S89463-10mg | 10mg | MedMol |
|
5-Ph-IAA
| S89463-25mg | 25mg | MedMol |
|
5-Ph-IAA
| S89463-100mg | 100mg | MedMol |
|
5-Ph-IAA
| S89463-5mg | 5mg | MedMol |
|
5-(thieno[2,3-d]pyrimidin-4-ylamino)naphthalen-1-ol
| S89847-5mg | 5mg | MedMol |
|
5-(thieno[2,3-d]pyrimidin-4-ylamino)naphthalen-1-ol
| S89847-10mg | 10mg | MedMol |
|
5-(thieno[2,3-d]pyrimidin-4-ylamino)naphthalen-1-ol
| S89847-25mg | 25mg | MedMol |
|
5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid, 6-[2-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-2-oxoethyl] 5-(1,1-dimethylethyl) este
| S83488-100mg | 100mg | MedMol |
|
5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid, 6-[2-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-2-oxoethyl] 5-(1,1-dimethylethyl) este
| S83488-250mg | 250mg | MedMol |
|
5,7-Dihydro-5-methyl-6H-dibenz[b,d]azepin-6-one
| S84371-250mg | 250mg | MedMol |
|
5-Benzoylbenzene-1,2,4-Tricarboxylic Acid
| S82982-100mg | 100mg | MedMol |
|
5-(苄基硫代)-N-甲基-1,3,4-噻二唑-2-胺
| T26952-5mg | 5mg | MedMol |
|
5-(苄基硫代)-N-甲基-1,3,4-噻二唑-2-胺
| T26952-10mg | 10mg | MedMol |
